News from the healthcare data industry
SAN FRANCISCO, March 3, 2022 /PRNewswire/ — NephroSant™ a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted kidneys, with a mission to significantly improve global kidney...
Abstract The landscape for evidence generation in hematologic malignancies is rapidly evolving. While randomized controlled trials (RCTs) remain the gold standard in support of drug efficacy, approval and use, the...
By Anastassia Gliadkovskaya Mar 1, 2022 12:45pmKomodo Health Black patients wait longer for diagnosis and treatment of colorectal cancer than their white counterparts do, a new study has revealed. The analysis was conducted...
Background Pediatric leukemia is the most prevalent childhood cancer in China and incurs heavy economic burden to patients without sufficient insurance protection. Although all Chinese children are obliged to enroll...
A new study found that some COVID-19 patients were diagnosed with shortness of breath, Type 2 diabetes and fatigue weeks after their initial infection.By Kat JercichFebruary 07, 202203:58 PM Photo: SHVETS...
The dermatology community remains concerned about the risk of COVID-19 in individuals with atopic dermatitis (AD). Using Symphony Health-derived data from the COVID-19 Research Database,1Â we aimed to assess the risk...
Abstract Background: The CARD study demonstrated superiority of cabazitaxel over abiraterone/enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) who received prior docetaxel and progressed ≤12 months on the alternative androgen-receptor-targeted...
BOSTON, Jan. 19, 2022 /PRNewswire/ — Analysis Group, a global leader in health economics and outcomes research (HEOR), announced that its groundbreaking method for generating real-world data (RWD) has proven both effective and...
Results validate company’s methodology and provide insight about the rapid evolution of future variants of concern January 18, 2022 08:45 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference, an AI-driven health...
Lyudmila Bazhenova, MD, and Federico Albrecht, MD, detailed the importance of using real-world evidence to inform treatment for patients with EGFR-mutated non–small cell lung cancer.https://embeds.audioboom.com/posts/8012579/embed/v4 As part of its Between...